Clinical Trials · NCT00065637
Once Weekly Parathyroid Hormone for Osteoporosis
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- University of California, San Francisco
- Enrollment
- 50
- Start date
- Dec 2003
- Locations
- 1 site, United States
- Primary endpoint
- Bone mineral density